Home > > > Report Detail

Global Prostate Cancer Market (by Cancer Type, Drug, Therapy & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

Publisher Name :
Date: 29-Sep-2020
No. of pages: 147
Inquire Before Buying

The global prostate cancer market is anticipated to reach US$14.41 billion in 2024, witnessing growth at a CAGR of 4.62%, over the period 2020-2024. Factors such as increasing geriatric population, rising healthcare expenditure, surging obese population, expanding urbanization, new drug approvals are expected to drive the market. The growth of the market would be challenged by severe side effects of the therapy, high cost associated with treatment and prolonged treatment durations. A few notable trends may include expansion of pharmaceutical industry, growing burden of prostate cancer and advancements in oncology.

The global prostate cancer market can be categorized on the basis of cancer type, drug and therapy. Depending upon the cancer type, the global prostate cancer market can broadly be divided into hormone refractory prostate cancer, hormone sensitive prostate cancer and other prostate cancer. According to drugs, the global prostate cancer market can be split into Enzalutamide, Abiraterone Acetate, Leuprorelin and other drugs. Whereas, in terms of therapy, the global prostate cancer market can be bifurcated into chemotherapy, targeted therapy, immunotherapy, hormonal therapy and other therapies.

The fastest growing regional market is North America due to rising prevalence of prostate cancer in the region, highly competitive and developed medical sector, high investment in research and development activities for the development of newer immunotherapies and targeted drug therapies to treat various cancers. Europe represents the second largest prostate cancer market and is already well-penetrated at developed market levels.

Scope of the report:


  • The report provides a comprehensive analysis of the global prostate cancer market segmented on the basis of cancer type, drug, therapy and region.

  • The major regional and country markets (North America, Europe, Asia Pacific and Rest of the World) have been analyzed.

  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

  • The competitive landscape of the market, along with the company profiles of leading players (Johnson & Johnson, Bayer AG, Sanofi S.A., AbbVie Inc., AstraZeneca PLC and Astellas Pharma, Inc.,) are also presented in detail.


Key Target Audience:


  • Prostate Cancer Drug Manufacturers

  • Prostate Cancer Medical Service Providers

  • Pharmaceuticals and Biopharmaceutical Firms

  • End Users (Hospitals, Cancer Research Institutes and Ambulatory & Radiotherapy Centers)

  • Government Bodies & Regulating Authorities

Global Prostate Cancer Market (by Cancer Type, Drug, Therapy & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

Table of Contents

1. Market Overview
1.1 Introduction
1.2 Types of Prostate Cancer
1.3 Staging and Grading
1.4 Symptoms of Prostate Cancer
1.5 Diagnosis of Prostate Cancer
1.6 Methods of Treatment 
1.7 Risk Factors for Prostate Cancer

2. Impact of COVID-19
2.1 Impact on Prostate Cancer Market
2.2 Impact on Cancer Prevalence
2.3 Risk Factors for Severe Adverse Events
2.4 Management of Prostate Cancer Patients During the COVID-19

3. Global Market Analysis
3.1 Global Prostate Cancer Market by Value
3.2 Global Prostate Cancer Market Forecast by Value
3.3 Global Prostate Cancer Market by Cancer Type
3.3.1 Global Hormone Refractory Prostate Cancer Market by Value 
3.3.2 Global Hormone Refractory Prostate Cancer Market Forecast by Value
3.3.3 Global Hormone Sensitive Prostate Cancer Market by Value 
3.3.4 Global Hormone Sensitive Prostate Cancer Market Forecast by Value
3.4 Global Prostate Cancer Market by Drug
3.4.1 Global Enzalutamide Prostate Cancer Market by Value
3.4.2 Global Enzalutamide Prostate Cancer Market Forecast by Value
3.4.3 Global Abiraterone Acetate Prostate Cancer Market by Value
3.4.4 Global Abiraterone Acetate Prostate Cancer Market Forecast by Value
3.4.5 Global Leuprorelin Prostate Cancer Market by Value
3.4.6 Global Leuprorelin Prostate Cancer Market Forecast by Value
3.5 Global Prostate Cancer Market by Therapy
3.5.1 Global Chemotherapy Prostate Cancer Market by Value
3.5.2 Global Chemotherapy Prostate Cancer Market Forecast by Value
3.5.3 Global Targeted Therapy Prostate Cancer Market by Value
3.5.4 Global Targeted Therapy Prostate Cancer Market Forecast by Value
3.5.5 Global Immunotherapy Prostate Cancer Market by Value
3.5.6 Global Immunotherapy Prostate Cancer Market Forecast by Value
3.5.7 Global Hormonal Therapy Prostate Cancer Market by Value
3.5.8 Global Hormonal Therapy Prostate Cancer Market Forecast by Value
3.6 Global Prostate Cancer Market by Region

4. Regional Market Analysis
4.1 North America
4.1.1 North America Prostate Cancer Market by Value
4.1.2 North America Prostate Cancer Market Forecast by Value
4.1.3 The U.S. Prostate Cancer Market by Value
4.1.4 The U.S. Prostate Cancer Market Forecast by Value
4.1.5 The U.S. Prostate Cancer Market by Drug
4.1.6 The U.S. Enzalutamide Prostate Cancer Market by Value
4.1.7 The U.S. Enzalutamide Prostate Cancer Market Forecast by Value
4.1.8 The U.S. Abiraterone Acetate Prostate Cancer Market by Value
4.1.9 The U.S. Abiraterone Acetate Prostate Cancer Market Forecast by Value
4.1.10 The U.S. Leuprorelin Prostate Cancer Market by Value
4.1.11 The U.S. Leuprorelin Prostate Cancer Market Forecast by Value
4.2 Europe
4.2.1 Europe Prostate Cancer Market by Value
4.2.2 Europe Prostate Cancer Market Forecast by Value
4.3 Asia Pacific
4.3.1 Asia Pacific Prostate Cancer Market by Value
4.3.2 Asia Pacific Prostate Cancer Market Forecast by Value
4.3.3 China Prostate Cancer Market by Value
4.3.4 China Prostate Cancer Market Forecast by Value
4.3.5 China Prostate Cancer Market by Drug
4.3.6 China Abiraterone Acetate Prostate Cancer Market by Value
4.3.7 China Abiraterone Acetate Prostate Cancer Market Forecast by Value
4.3.8 China Bicalutamide Prostate Cancer Market by Value
4.3.9 China Bicalutamide Prostate Cancer Market Forecast by Value
4.3.10 China Docetaxel Prostate Cancer Market by Value
4.3.11 China Docetaxel Prostate Cancer Market Forecast by Value
4.4 RoW
4.4.1 RoW Prostate Cancer Market by Value
4.4.2 RoW Prostate Cancer Market Forecast by Value

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Geriatric Population
5.1.2 Rising Healthcare Expenditure
5.1.3 Surging Obese Population
5.1.4 Rapid Urbanization 
5.1.5 New Drug Approvals
5.2 Key Trends and Developments
5.2.1 Growth of Pharmaceutical Industry
5.2.2 Growing Burden of Prostate Cancer
5.2.3 Advancements in Oncology
5.2.4 Increasing Public Awareness
5.3 Challenges
5.3.1 Severe Side Effects of Treatment
5.3.2 High Cost Associated with Treatment 
5.3.3 Prolonged Treatment Durations

6. Competitive Landscape
6.1 Global Market
6.1.1 Revenue Comparison of Key Players
6.1.2 Market Capitalization Comparison of Key Players
6.1.3 R&D Comparison of Key Players 
6.2 Approved Drugs for Prostate Cancer
6.3 Experimental Agents of Prostate Cancer

7. Company Profiles
7.1 Johnson & Johnson
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Bayer AG
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Sanofi S.A.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 AbbVie Inc.
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies
7.5 AstraZeneca PLC 
7.5.1 Business Overview
7.5.2 Financial Overview
7.5.3 Business Strategies
7.6 Astellas Pharma, Inc.
7.6.1 Business Overview
7.6.2 Financial Overview
7.6.3 Business Strategies

List of Tables

Prostate Cancer Stages
Risk Factors for Severe Adverse Events (2020)
Severe Side-Effects by Type of Treatment 
Revenue Comparison of Key Players (2019)
Market Capitalization Comparison of Key Players (2020)
R&D Expenditure Comparison of Key Players (2019)
Approved Drugs for Prostate Cancer
Experimental Agents of Prostate Cancer

List of Figures

Types of Prostate Cancer
Symptoms of Prostate Cancer
Types of Tests for Diagnosis of Prostate Cancer
Methods of Treatment 
Risk Factors for Prostate Cancer
Global Cancer Prevalence (2018-2023)
Management of Prostate Cancer Patients During the COVID-19 
Global Prostate Cancer Market by Value (2015-2019)
Global Prostate Cancer Market Forecast by Value (2020-2024)
Global Prostate Cancer Market by Cancer Type (2019)
Global Hormone Refractory Prostate Cancer Market by Value (2015-2019)
Global Hormone Refractory Prostate Cancer Market Forecast by Value (2020-2024)
Global Hormone Sensitive Prostate Cancer Market by Value (2015-2019)
Global Hormone Sensitive Prostate Cancer Market Forecast by Value (2020-2024)
Global Prostate Cancer Market by Drug (2019)
Global Enzalutamide Prostate Cancer Market by Value (2015-2019)
Global Enzalutamide Prostate Cancer Market Forecast by Value (2020-2024)
Global Abiraterone Acetate Prostate Cancer Market by Value (2015-2019)
Global Abiraterone Acetate Prostate Cancer Market Forecast by Value (2020-2024)
Global Leuprorelin Prostate Cancer Market by Value (2015-2019)
Global Leuprorelin Prostate Cancer Market Forecast by Value (2020-2024)
Global Prostate Cancer Market by Therapy (2019)
Global Chemotherapy Prostate Cancer Market by Value (2015-2019)
Global Chemotherapy Prostate Cancer Market Forecast by Value (2020-2024)
Global Targeted Therapy Prostate Cancer Market by Value (2015-2019)
Global Targeted Therapy Prostate Cancer Market Forecast by Value (2020-2024)
Global Immunotherapy Prostate Cancer Market by Value (2015-2019)
Global Immunotherapy Prostate Cancer Market Forecast by Value (2020-2024)
Global Hormonal Therapy Prostate Cancer Market by Value (2015-2019)
Global Hormonal Therapy Prostate Cancer Market Forecast by Value (2020-2024)
Global Prostate Cancer Market Value by Region (2019)
North America Prostate Cancer Market by Value (2015-2019)
North America Prostate Cancer Market Forecast by Value (2020-2024)
The U.S. Prostate Cancer Market by Value (2015-2019)
The U.S. Prostate Cancer Market Forecast by Value (2020-2024)
The U.S. Prostate Cancer Market by Drug (2019)
The U.S. Enzalutamide Prostate Cancer Market by Value (2015-2019)
The U.S. Enzalutamide Prostate Cancer Market Forecast by Value (2020-2024)
The U.S. Abiraterone Acetate Prostate Cancer Market by Value (2015-2019)
The U.S. Abiraterone Acetate Prostate Cancer Market Forecast by Value (2019-2024)
The U.S. Leuprorelin Prostate Cancer Market by Value (2015-2019)
The U.S. Leuprorelin Prostate Cancer Market Forecast by Value (2020-2024)
Europe Prostate Cancer Market by Value (2015-2019)
Europe Prostate Cancer Market Forecast by Value (2020-2024)
Asia Pacific Prostate Cancer Market by Value (2015-2019)
Asia Pacific Prostate Cancer Market Forecast by Value (2020-2024)
China Prostate Cancer Market by Value (2015-2019)
China Prostate Cancer Market Forecast by Value (2020-2024)
China Prostate Cancer Market by Drug (2019)
China Abiraterone Acetate Prostate Cancer Market by Value (2015-2019)
China Abiraterone Acetate Prostate Cancer Market Forecast by Value (2020-2024)
China Bicalutamide Prostate Cancer Market by Value (2015-2019)
China Bicalutamide Prostate Cancer Market Forecast by Value (2020-2024)
China Docetaxel Prostate Cancer Market by Value (2015-2019)
China Docetaxel Prostate Cancer Market Forecast by Value (2020-2024)
RoW Prostate Cancer Market by Value (2015-2019)
RoW Prostate Cancer Market Forecast by Value (2020-2024)
Global Population Above 65 Years (2015-2019)
Global Healthcare Expenditure Per Capita (2015-2019)
Global Obese Population (2014-2019)
Global Urban Population (2014-2019)
CDER’s Novel Drug Approvals (2010-2019)
Global Pharmaceutical Market Revenue (2001-2021)
Total Number of Prostate Cancer Patients in the U.S. Rate (2018-2026)
Johnson & Johnson Sales and Net Earnings (2015-2019)
Johnson & Johnson Sales by Segment (2019)
Johnson & Johnson Sales by Region (2019)
Bayer AG Sales and Net Income (2015-2019)
Bayer AG Sales by Segment (2019)
Bayer AG Sales by Region (2019)
Sanofi S.A. Net Sales and Net Income (2015-2019) 
Sanofi S.A. Net Sales by Segment (2019)
Sanofi S.A. Net Sales by Region (2019)
AbbVie Inc. Net Revenue and Net Earnings (2015-2019)
AbbVie Inc. Net Revenue by Region (2019)
AstraZeneca PLC Total Revenue and Profit (2015-2019)
AstraZeneca PLC Total Revenue by Region (2019)
Astellas Pharma, Inc. Revenue and Profit (2015-2019)
Astellas Pharma, Inc. Revenue by Product & Service (2019)
Astellas Pharma, Inc. Revenue by Region (2019)

  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs